BetterScholar BetterScholar
12
Role
Title
Level Year L/R
🐜 Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.
13 auth. I. Rapado, L. Shulman, H. Fleisch, P. Stern, C. Gennari, R. Morita, H. Genant, P. Burckhardt, C. Christiansen, W. Peck, ... E. Ogata, T. Martin, Luciano Martini
11 1993
11
🐜
🐢 Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.
W. A. D'Angelo, J. Fries, A. Masi, L. Shulman
10 1969
10
🐢
🐢 Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus.
M. Merrell, L. Shulman
9 1955
9
🐢
🐢 Controlled trial of cyclophosphamide in rheumatoid arthritis.
A. Townes, J. Sowa, L. Shulman
7 1976
7
🐢
🦁 Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?
L. Shulman
7 1984
7
🦁
🐢 Research directions in osteoporosis.
7 auth. W. Peck, B. Riggs, N. Bell, R. Wallace, C. Johnston, S. Gordon, ... L. Shulman
6 1988
6
🐢
🐢 Histocompatibility antigens in systemic lupus erythematosus.
Marc A. Goldberg, F. Arnett, F. Arnett, W. Bias, L. Shulman
6 1976
6
🐢
🐢 Workshop on etiopathogenesis of osteoarthritis, Warrenton VA, July 21-25, 1985: reasearch recommendations arising from the workshop
H. Mankin, K. Brandt, L. Shulman
6 1986
6
🐢
🐢 Diffuse fasciitis with eosinophilia: A clinicopathologic study
H. Moutsopoulos, B. Webber, N. Pavlidis, G. Fostiropoulos, D. Goules, L. Shulman
6 1980
6
🐢
🐢 The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma).
E. Velayos, A. Masi, M. Stevens, L. Shulman
6 1979
6
🐢
🐢 Papular mucinosis. A clinicopathologic study of four patients.
E. Farmer, G. Hambrick, L. Shulman
6 1982
6
🐢
🐢 Suggestions for future research directions resulting from this workshop
B. Schwartz, F. Arnett, M. Khan, G. Nepom, P. Stastny, L. Shulman
5 1988
5
🐢